Shock deal! Carlyle to snap up Baxter’s kidney care business for $3.8bn—Here’s why it matters

In a landmark move for the medtech industry, Carlyle Group (NASDAQ) has announced its decision to acquire Baxter International Inc.'s (NYSE) Kidney Care segment for ... Read More